Clinical Trial: Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108595) titled 'Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study' on July 31.

Brief Summary: Evaluate the efficacy and safety of T-DXd in patients with HER2-positive and HER2-low metastatic breast cancer

Study Start Date: Jan. 01, 2021

Study Type: OBSERVATIONAL

Condition: Breast Cancer

Intervention: DRUG: T- Dxd

T-DXd based therapy

Recruitment Status: COMPLETED

Sponsor: The First Affiliated Hospital with Nanjing Medical University

Disclaimer: Curated by HT Syndication....